Diffuse Large B Cell Lymphoma and Clinical Intervention
2nd International Conference on Hematology and Oncology
August 23-24, 2018 | London, UK
Ashok Srivastava
Clinfomatrix Oncology, USA
Posters & Accepted Abstracts : Hematol Blood Disord
Abstract:
Diffuse large B-cell lymphoma: It is the most common type of non-Hodgkin lymphoma among adults. Diffuse large B-cell lymphoma occurs primarily in older individuals, with a median age of diagnosis at approximately 65-70 years of age, though it can also occur in children and young adults in rare cases. Diffuse large B-cell lymphoma is an aggressive tumor, sometimes associated with fever, weight loss, and night sweats. The cause of diffuse large B-cell lymphoma is not well understood. Typically, diffuse large B-cell lymphoma arises from normal B cells, but it can also represent a malignant transformation of other types of lymphoma or leukemia. However, the usual treatment of these is chemotherapy, often in combination with an antibody targeted at the tumor cells. However, survival rate of patients varies. The details of the clinical data will be presented.
Biography:
E-mail:
ashok.srivastava@curepharmaceuticaslinc.comPDF HTML